6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
1h ago	Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
1h ago	The Trade Desk Powers Open Internet Growth with DramaBox Short Drama Partnership
2h ago	Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
3h ago	Sun Pharma signs Definitive Agreement to Acquire Organon
6h ago	Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

About

Trisalus Life Sciences Inc. (NASDAQ:TLSI) — investor relations, events, news, and company updates on 6ix.

Latest News

TriSalus Life Sciences Appoints Richard Marshall, M.D., as Chief Medical Officer

TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models

TriSalus Life Sciences Reports Fourth Quarter and Year-End 2025 Results and Reaffirms 2026 Revenue Guidance

TriSalus Life Sciences to Host Fourth Quarter 2025 Financial Results Conference Call

TriSalus Life Sciences Announces Pricing of $40.0 Million Public Offering

Financials

Revenue

$45.15 M

Market Cap

$250.57 M

EPS

-1.84

Community Chat

Ask AI